tiprankstipranks
Trending News
More News >
Maravai Lifesciences Holdings (MRVI)
NASDAQ:MRVI
US Market
Advertisement

Maravai Lifesciences Holdings (MRVI) Earnings Dates, Call Summary & Reports

Compare
410 Followers

Earnings Data

Report Date
Feb 25, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.07
Last Year’s EPS
-0.06
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted significant cost reductions and new product innovations, indicating potential for future growth. However, it was overshadowed by substantial revenue declines and negative EBITDA, primarily due to order timing and macroeconomic challenges.
Company Guidance
During Maravai LifeSciences' third quarter 2025 earnings call, the company provided guidance for the remainder of the year and into 2026. They anticipate closing 2025 with revenue of approximately $185 million, implying a Q4 growth of 18% over the third quarter. Excluding GMP COVID CleanCap, Q4 base business growth is expected to be 16% year-over-year. Additionally, the company forecasts a 2025 adjusted EBITDA loss of about $35 million, translating to an adjusted EBITDA loss of $3.5 million in Q4. Looking ahead, Maravai expects to return to positive adjusted EBITDA and cash flow in 2026, driven by a streamlined cost structure with annualized expenses reduced by over $50 million. The company also noted strong order velocity for GMP consumables into 2026, bolstered by multiyear supply agreements and a strategic focus on operational excellence and revenue growth.
Biologic Safety Testing Growth
Biologic Safety Testing (BST) generated $16.3 million in revenue, growing at 7% year-over-year, with strong demand from core markets in the Americas and Europe, up 8% and 17% respectively.
Cost Structure Realignment
The company has stabilized operations and significantly reduced expenses, targeting an annualized reduction of over $50 million, with $7 million expected in sequential adjusted EBITDA improvement in Q4.
Innovation and Product Launches
The launch of ModTail technology, which enhances mRNA protein expression, and the IVT kits have shown early success, with consistent bookings growth and positive reception from new and existing customers.

Maravai Lifesciences Holdings (MRVI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MRVI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 2026
2025 (Q4)
-0.07 / -
-0.06
Nov 06, 2025
2025 (Q3)
-0.08 / -0.08
-0.02-300.00% (-0.06)
Aug 11, 2025
2025 (Q2)
-0.07 / -0.08
0
May 12, 2025
2025 (Q1)
-0.07 / -0.08
-0.02-300.00% (-0.06)
Mar 18, 2025
2024 (Q4)
-0.04 / -0.06
0.01-700.00% (-0.07)
Nov 07, 2024
2024 (Q3)
>-0.01 / -0.02
-0.01-100.00% (-0.01)
Aug 07, 2024
2024 (Q2)
<0.01 / 0.00
0
May 08, 2024
2024 (Q1)
-0.03 / -0.02
0.03-166.67% (-0.05)
Feb 22, 2024
2023 (Q4)
-0.01 / 0.01
0.35-97.14% (-0.34)
Nov 07, 2023
2023 (Q3)
<0.01 / -0.01
0.37-102.70% (-0.38)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MRVI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$2.89$2.87-0.69%
Aug 11, 2025
$2.06$2.69+30.58%
May 12, 2025
$2.12$2.06-2.83%
Mar 18, 2025
$2.58$2.43-5.81%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Maravai Lifesciences Holdings (MRVI) report earnings?
Maravai Lifesciences Holdings (MRVI) is schdueled to report earning on Feb 25, 2026, After Close (Confirmed).
    What is Maravai Lifesciences Holdings (MRVI) earnings time?
    Maravai Lifesciences Holdings (MRVI) earnings time is at Feb 25, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MRVI EPS forecast?
          MRVI EPS forecast for the fiscal quarter 2025 (Q4) is -0.07.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis